Justin A. Renz
CFO · ZEVRA THERAPEUTICS, INC.
- 2024
- Mar 19, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Justin A. Renz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael Raab - $2.57M in ARDX purchases and sales in the last 12 months
- David M. Mott - $1.95M in ARDX purchases and sales in the last 12 months
- Neil F. McFarlane - $1.20M in ZVRA purchases and sales in the last 12 months
- Rahsaan Thompson - $969K in ZVRA purchases and sales in the last 12 months
- Laura A. Williams - $659K in ARDX purchases and sales in the last 12 months
- Eric Duane Foster - $176K in ARDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Justin A. Renz?
Justin A. Renz is a corporate insider, tracked as CFO of ZEVRA THERAPEUTICS, INC. (ZVRA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Justin A. Renz last file a Form 4?
The most recent primary Form 4 on record is dated 19 March 2026, one of 3 filings going back to 2024.
Has Justin A. Renz been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($67K) across all tracked filings.
